Member Posts > Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): Leading Innovation in Heart Health
Cardiol Therapeutics is revolutionizing cardiovascular care, driving advancements in the treatment of inflammatory heart diseases through cutting-edge research. Their lead therapy, CardiolRx™, a high-purity cannabidiol formulation, is being developed to treat pericarditis, myocarditis, and heart failure, providing new hope for patients with serious cardiac conditions.
With a commitment to scientific excellence, patient-focused care, and breakthrough medical solutions, Cardiol Therapeutics is shaping the future of cardiovascular medicine and redefining treatment possibilities.

#CardiolTherapeutics #CardiolRx #HeartHealth #MedicalInnovation #CBDTherapy #CardiacCare #Biotech #FutureOfMedicine #CRD38 #Myocarditis #Pericarditis